While the ESCRT-III protein CHMP2B was first genetically linked to FTD [23], copy number variation in CHMP2B has since been reported in a family with familial Alzheimer’s disease [24] and genome-wide association studies for late onset AD identified an association with VPS4B [25]. This evidence concerns the gene CHMP2B and Alzheimer disease.